Europe PMCopen access
Developing low-carbon salbutamol MDI: assessment of relative bioavailability and pharmacodynamic relative potency of salbutamol MDI with propellant HFA-152a
Asthma, Copd Pharmacology, Inhaler Devices, Asthma Pharmacology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 314809
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.